THC, Cannabis, and Psychosis
common.study.values.description
“Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I”
The overall purpose of this study is to examine the effect of Pregnenolone (PREG) on the acute psychosis-like and cognitive effects of Delta-9-Tetrahydrocannabinol (THC). This will be tested by pretreating healthy individuals with PREG, and then assessing their responses to Dronabinol (THC).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Active Dronabinol
20 mg capsule of Dronabinol will be administered orally
Drug - Active Pregnenolone
1.79 mg/kg of Pregnenolone will be administered sublingually (under the tongue)
Drug - Placebo Dronabinol
Control: Placebo pill (no active cannabinoids) administered orally
Drug - Placebo Pregnenolone
Control: Placebo given sublingually (under the tongue)
participant.views.study.view.additional
participant.views.study.view.scientific-title
Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I
common.study.values.clinical-trial-id
NCT02811939
participant.views.study.view.id
9aAr9b
